Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Polyrizon Ltd. ( (PLRZ) ) is now available.
On December 5, 2025, Polyrizon Ltd. announced a securities purchase agreement with investors for the sale of 552,269 ordinary shares at $9.00 per share, exceeding Nasdaq’s minimum price requirements. The offering, expected to close on the same day, aims to raise approximately $4.97 million, which will be used for general corporate purposes, including operations, capital expenditures, and strategic opportunities. This move is expected to bolster Polyrizon’s financial standing and support its growth initiatives in the biotechnology industry.
More about Polyrizon Ltd.
Polyrizon Ltd. operates in the biotechnology sector, focusing on developing innovative solutions for the protection of biological systems against biological threats and allergens. The company is based in Raanana, Israel, and is engaged in technology development and strategic acquisitions to enhance its market position.
Average Trading Volume: 3,124,210
Technical Sentiment Signal: Sell
Current Market Cap: $14.47M
Learn more about PLRZ stock on TipRanks’ Stock Analysis page.